Drug trial tests hope for debilitating muscle disease in teens and adults

This study tested whether a drug called Tideglusib is safe and helpful for adolescents and adults with a severe, early-onset form of myotonic dystrophy, a genetic muscle-wasting disease. Sixteen participants aged 12 to 45 took the drug to see if it could improve muscle function, strength, and daily activities. The main goal was to check for side effects and see how the body processes the drug, while also measuring changes in walking, grip strength, and overall health.